Page last updated: 2024-10-29

ifosfamide and Histiocytic Sarcoma

ifosfamide has been researched along with Histiocytic Sarcoma in 2 studies

Histiocytic Sarcoma: Malignant neoplasms composed of MACROPHAGES or DENDRITIC CELLS. Most histiocytic sarcomas present as localized tumor masses without a leukemic phase. Though the biological behavior of these neoplasms resemble lymphomas, their cell lineage is histiocytic not lymphoid.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Nakamura, Y1
Takemasa, A1
Kushima, Y1
Soda, S1
Ikeda, N1
Arai, R1
Chibana, K1
Nakazato, Y1
Yokose, T1
Shimizu, Y1
Niho, S1
Ferringer, T1
Banks, PM1
Metcalf, JS1

Other Studies

2 other studies available for ifosfamide and Histiocytic Sarcoma

ArticleYear
A case of spindle cell dominant histiocytic sarcoma showing a complete remission after first-line chemotherapy with doxorubicin and ifosfamide.
    Journal of chemotherapy (Florence, Italy), 2020, Volume: 32, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Doxorubicin; Histiocytic Sarc

2020
Langerhans cell sarcoma.
    The American Journal of dermatopathology, 2006, Volume: 28, Issue:1

    Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Disease-Free Survival; Doxoru

2006